查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
類器官服務市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用、來源和地理位置
市場調查報告書
商品編碼
1558383

類器官服務市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用、來源和地理位置

Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography
出版日期: | 出版商: The Insight Partners | 英文 168 Pages | 訂單完成後即時交付

價格

依據「2031 年類器官服務市場預測 - 全球分析 - 按類型、應用、來源和地理位置」的新研究，該市場預計將從 2023 年的 30.3 億美元成長到 15.01 美元到2031 年將達到10億；預計 2023-2031 年複合年成長率為 22.3%。促進類器官服務市場成長的因素包括對新型藥物篩選服務的需求不斷成長，以及定製藥物的普及。然而，缺乏熟練的專業人員和嚴格的安全法規阻礙了市場的成長。

類器官是基於細胞的簡單組織工程體外模型，概括了相應體內組織複雜結構和功能的許多方面。它們可以被解剖和詢問，用於人體組織發育、再生和修復的基本機制研究，也可以用於診斷、疾病建模、藥物發現和個人化醫療。

北美主導著類器官服務市場。美國的市場參與者正專注於有機成長策略以鞏固自己的立足點。 2023 年 2 月，Molecular Devices, LLC。和 HUB Organoids (HUB) 宣布開展策略合作，繼續開發下一代 3D 生物學技術，推動臨床前到臨床藥物損耗的逐步減少。此外，不斷增加的研究和開發活動、對組織工程和器官移植的需求不斷成長以及類器官的高採用率正在推動該國的類器官服務市場。類器官有潛力克服先前與生物醫學研究相關的幾個局限性，重點關注為研究人員提供有關人類發育的機制見解，產生準確的人類疾病模型，並為再生醫學產生與患者匹配的組織來源。預計亞太地區 2023 年至 2031 年複合年成長率最高。

加大重點開發力度，為未來提供市場機會

醫療保健產業的進步導致全球對類器官的需求增加。這種需求的增加有助於全球範圍內的新產品開發、收購、合作、產品發布和批准。主要市場參與者參與活動，以確保高效服務和產品的創新和開發。以下列出了最近的一些關鍵進展：

2024 年 6 月，Molecular Devices, LLC。其在英國卡迪夫的專用工廠正式開幕。這座耗資數百萬英鎊的設施旨在適應該業務的獨特生物程序流程和創新生物反應器技術，從而實現 PDO 的大規模、品質控制生產。大量 3D 就緒的可重複 PDO 可作為客製化服務提供，並以可用於分析的方式冷凍保存。研究人員可以根據需要解凍、電鍍和使用這些產品。

2024年5月，生技公司InSphero與法蘭克福Genome Biologics簽署了合作協議。透過此次合作，InSphero 將獲得 Genome Biologics 3D 心臟類器官平台商業化的全球專屬權利。該平台提供準確、可擴展且針對特定疾病的類器官模型，用於創建新的治療方法，使其處於心臟病研究的前沿。

2023 年 7 月，Molecular Devices 推出了客製化類器官產品線擴展服務，採用獨特的生物製程技術，適用於高通量應用。

2023 年 2 月，Molecular Devices, LLC. 和 HUB Organoids (HUB) 宣布開展策略合作，共同致力於下一代 3D 生物技術的持續開發，從而逐步減少臨床前到臨床的藥物損耗。

2022 年 12 月，Molecular Devices, LLC。收購了 Cellesce Ltd。

2021年8月，STEMCELL Technologies與Hubrecht Organoid Technology (HUB)簽署協議。作為該協議的一部分，STEMCELL 的合約檢測服務部門開始向 HUB 提供其組織源類器官，例如肺、腸和肝臟類器官，用於臨床前毒理學篩檢和非癌症藥物開發服務。這些服務將促進研究人員和藥物開發組織將類器官整合到臨床前測試計畫中，以幫助更快、更經濟地推出新療法。

市場參與者之間的此類關鍵開發、發布和策略合作為類器官服務市場的成長創造了充足的機會。

基於應用程式的見解

按應用分類，市場分為發育生物學、傳染病病理學、再生醫學、藥物毒性和功效測試、藥物發現和個人化醫療等。 2023年，發育生物學疾病領域佔最大市場佔有率；預計 2023 年至 2031 年複合年成長率將達到最高。

基於來源的見解

根據來源，類器官服務市場分為多能幹細胞和器官特異性成體幹細胞。到 2023 年，多能幹細胞細分市場將佔據更大的市場佔有率。

類器官服務市場：競爭格局與主要發展

中華生物製藥股份有限公司； Eurofins Scientific SE；分子裝置有限責任公司； InSphero；賽普勒斯;創新服務；實驗室；庫薩比奧科技有限責任公司；腫瘤設計服務；和 HUB Organoids BV（Hubrecht Organoid Technology）是類器官服務市場上的主要公司之一。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 和全球疾病負擔研究是準備類器官服務市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：類器官服務市場格局

  • PEST分析

第 5 章：類器官服務市場 - 主要市場動態

  • 類器官服務市場 - 主要市場動態
  • 市場促進因素
    • 創新藥物篩選服務的需求不斷增加
    • 個人化藥物的受歡迎程度激增
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 增加關鍵發展
  • 未來趨勢
    • 人工智慧整合
  • 促進因素和限制的影響：

第 6 章：類器官服務市場 - 全球市場分析

  • 類器官服務市場收入，2021-2031
  • 類器官服務市場預測分析

第 7 章：類器官服務市場分析 - 按類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第 8 章：類器官服務市場分析 - 按應用

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和藥效測試
  • 藥物發現與個人化醫療
  • 其他

第 9 章：類器官服務市場分析 - 按來源

  • 多能幹細胞
  • 器官特異性成體幹細胞

第 10 章：類器官服務市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 概述
  • 類器官服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附錄

Product Code: TIPRE00039302

According to our new research study on "Organoids Services Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.3% during 2023-2031. Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.

Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.

North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.

Increasing Key Developments to Provide Market Opportunities in Future

The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:

In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.

In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.

In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.

In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.

In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.

In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.

Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth..

Application -Based Insights

By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.

Source -Based Insights

Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.

Organoids services Market: Competitive Landscape and Key Developments

Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids services market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids services market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Organoids Services Market - Key Market Dynamics

  • 5.1 Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Organoids Services Market - Global Market Analysis

  • 6.1 Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Organoids Services Market Forecast Analysis

7. Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Services Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Organoids Services Market Overview
    • 10.2.2 North America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Organoids Services Market Breakdown, by Type
      • 10.2.3.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: Organoids Services Market Breakdown, by Application
      • 10.2.4.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: Organoids Services Market Breakdown, by Source
      • 10.2.5.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.2.6 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
        • 10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
        • 10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
      • 10.2.6.3 Canada: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
        • 10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
        • 10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
      • 10.2.6.4 Mexico: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
        • 10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
  • 10.3 Europe
    • 10.3.1 Europe Organoids Services Market Overview
    • 10.3.2 Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Organoids Services Market Breakdown, by Type
      • 10.3.3.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: Organoids Services Market Breakdown, by Application
      • 10.3.4.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: Organoids Services Market Breakdown, by Source
      • 10.3.5.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.3.6 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
        • 10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
        • 10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
      • 10.3.6.3 United Kingdom: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
        • 10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
      • 10.3.6.4 France: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
        • 10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
        • 10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
      • 10.3.6.5 Italy: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
        • 10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
        • 10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
      • 10.3.6.6 Spain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
        • 10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
        • 10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
      • 10.3.6.7 Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
        • 10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Organoids Services Market Overview
    • 10.4.2 Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
      • 10.4.5.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.4.6 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 Japan: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
        • 10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
        • 10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
      • 10.4.6.3 China: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
        • 10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
        • 10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
      • 10.4.6.4 India: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
        • 10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
        • 10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
      • 10.4.6.5 South Korea: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
        • 10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
        • 10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
      • 10.4.6.6 Australia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
        • 10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
        • 10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
      • 10.4.6.7 Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
        • 10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Organoids Services Market Overview
    • 10.5.2 Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
      • 10.5.5.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.5.6 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
        • 10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
      • 10.5.6.3 South Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
        • 10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
      • 10.5.6.4 United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
        • 10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
      • 10.5.6.5 Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
        • 10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
  • 10.6 South and Central America
    • 10.6.1 South and Central America Organoids Services Market Overview
    • 10.6.2 South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
      • 10.6.3.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
      • 10.6.4.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
      • 10.6.5.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.6.6 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
        • 10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
      • 10.6.6.3 Argentina: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
        • 10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
      • 10.6.6.4 Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
        • 10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Organoids Services Market Segmentation
  • Table 2. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Source
  • Table 6. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 7. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 8. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 9. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 10. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 11. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 12. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 13. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 14. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 15. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 16. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 19. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 20. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 22. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 23. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 24. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 26. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 27. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 28. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 29. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 31. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 32. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 35. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 36. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 38. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 39. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 40. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 41. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 42. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 43. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 45. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 46. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 47. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 48. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 49. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 52. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 53. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 54. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 55. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 56. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 57. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 58. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 59. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 60. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 63. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 64. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 65. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 66. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 67. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 68. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 69. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 70. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 71. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 72. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 73. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 74. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 75. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 76. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 79. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 80. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 81. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 82. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 83. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 84. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 85. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 86. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 87. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 88. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 89. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 91. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 92. Recent Organic Growth Strategies in Organoids Services Market
  • Table 93. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 94. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Organoids Services Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Organoids Services Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 25. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. North America: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 27. North America: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 28. North America: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 29. North America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 30. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Europe: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 35. Europe: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 36. Europe: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 37. Europe: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 38. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Asia Pacific: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 46. Asia Pacific: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 47. Asia Pacific: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 48. Asia Pacific: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 49. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Middle East and Africa: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 57. Middle East and Africa: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 58. Middle East and Africa: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 59. Middle East and Africa: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 60. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 64. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 65. South and Central America: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 66. South and Central America: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 67. South and Central America: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 68. South and Central America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 69. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Growth Strategies in Organoids Services Market